共 50 条
- [45] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
- [48] Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real-world experience of a referral center EJHAEM, 2023, 4 (02): : 470 - 475